DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Sai Parenterals Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·1 Oct 2026, 12:10 pm

SAI Parenterals

Sai Parenterals Limited has announced the schedule for its upcoming meeting with analysts and institutional investors. This event is part of the company's standard practice to engage with the investment community and provide updates on its business operations.

For investors, this meeting is significant as it offers a direct platform for the company to communicate its strategy, financial outlook, and address any queries from the market. Such interactions often provide valuable insights into management's confidence and future plans, which can be a key factor for retail investors in their decision-making process.

Market participants should watch for any specific guidance or commentary regarding the company's performance, product pipeline, or expansion plans shared during the interaction. Keeping an eye on the company's official filings and subsequent press releases will be essential to fully understand the implications of this investor meet.